Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 17313  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (85 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    Viewed4611    
    Printed190    
    Emailed0    
    PDF Downloaded186    
    Comments [Add]    

Recommend this journal


 


 
EXPERT'S COMMENTS
Year : 2005  |  Volume : 51  |  Issue : 3  |  Page : 168

The potential use of the leptospiral major outer membrane lipoprotein LipL32 in the diagnosis of leptospirosis


KIT Biomedical Research Royal Tropical Institute / Koninklijk Instituut voor de Tropen (KIT), Meibergdreef 39 1105 AZ Amsterdam, Netherlands, The

Correspondence Address:
Henk L Smits
KIT Biomedical Research Royal Tropical Institute / Koninklijk Instituut voor de Tropen (KIT), Meibergdreef 39 1105 AZ Amsterdam
Netherlands, The
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions




How to cite this article:
Smits HL. The potential use of the leptospiral major outer membrane lipoprotein LipL32 in the diagnosis of leptospirosis. J Postgrad Med 2005;51:168

How to cite this URL:
Smits HL. The potential use of the leptospiral major outer membrane lipoprotein LipL32 in the diagnosis of leptospirosis. J Postgrad Med [serial online] 2005 [cited 2023 Sep 27];51:168. Available from: https://www.jpgmonline.com/text.asp?2005/51/3/168/19014


Standard diagnostic tests for leptospirosis such as the microscopic agglutination test (MAT) and ELISA are based on the detection of lipopolysaccharide (LPS) specific antibodies in human serum samples. LPS specific antibodies may remain present at detectable levels for a relatively long period and some individuals remain positive for months or even years after recovery. In endemic areas, this may lead to an unwanted low specificity of these tests. A recent study showed that the seroprevalence for leptospirosis (as determined in IgM ELISA) was as high as 28% in the Amazon area of Peru.[1] The leptospiral major outer membrane lipoprotein LipL32 is expressed during infection by all pathogenic strains and can prove to be an important candidate antigen for the development of a sensitive and specific test for leptospirosis.[2] It was shown that LipL32 can be used as antigen in IgG ELISA.[3] Culture, MAT and ELISA can be applied in well-equipped laboratories by trained staff. However, only very few diagnostic facilities have the capacity and expertise to perform these tests for leptospirosis. Simple and rapid tests for leptospirosis are available that can be easily used by health staff outside these specialised laboratories.[4],[5] These so-called point-of-care tests use LPS as the antigen. It is important to determine whether the use of LipL32 will improve the assay characteristics and clinical utility of these rapid tests.

 
 :: References Top

1.Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, et al . Environmental exposure and leptospirosis, Peru. Emerg Infect Dis 2004;10:1016-22.  Back to cited text no. 1    
2.Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, et al . The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 2000;68:2276-85.  Back to cited text no. 2    
3.Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, Da Silva ED, et al . Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol 2001;39:3303-10.  Back to cited text no. 3    
4.Eapen CK, Sugathan S, Kuriakose M, Abdoel T, Smits HL. Evaluation of the clinical utility of a rapid blood test for human leptospirosis. Diagn Microbiol Infect Dis 2002;42:221-5.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Smits HL, Chee HD, Eapen CK, Kuriakose M, Sugathan S, Gasem MH, et al . Latex based, rapid and easy assay for human leptospirosis in a single test format. Trop Med Int Health 2001;6:114-8.  Back to cited text no. 5    




 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow